SLC5A2 and type 2 diabetes mellitus: Although new OHA, such as dipeptidyl peptidase 4 inhibitor (DPP-4 inhibitor) and sodium–glucose cotransporter 2 inhibitor (SGLT-2 inhibitor), are broadly used these days, they were not available for T2DM medication at that time.